Condition
Open Wound
Total Trials
6
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 1 (1)
Trial Status
Recruiting3
Completed2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06918561Not ApplicableRecruitingPrimary
Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds
NCT07041177Not ApplicableCompletedPrimary
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open Wounds
NCT07396376Phase 1Recruiting
Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers
NCT05169814Early Phase 1RecruitingPrimary
Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds
NCT04018469Withdrawn
Patterned Electric Dressing Effects on Open Wounds
NCT02332993Completed
Nutritional Regulation of Wound Inflammation: Part III
Showing all 6 trials